BASI, A Potent Small Molecular Inhibitor, Inhibits Glioblastoma Progression by Targeting microRNA-mediatedβ-Catenin Signaling

Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas

(2013) Kai-liang Zhang et al.   CANCER LETTERS

AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial-Mesenchymal Transition and Suppresses Tumor Growth and Progression

(2013) Z. Shi et al.   CANCER RESEARCH

A DNA Methylation Prognostic Signature of Glioblastoma: Identification of NPTX2-PTEN-NF- B Nexus

(2013) S. Shukla et al.   CANCER RESEARCH

MicroRNA-218 Inhibits Glioma Invasion, Migration, Proliferation, and Cancer Stem-like Cell Self-Renewal by Targeting the Polycomb Group Gene Bmi1

(2013) Y. Tu et al.   CANCER RESEARCH

Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway

(2013) Xu Sun et al.   CELLULAR SIGNALLING

Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway

(2013) Kaijie He et al.   INTERNATIONAL JOURNAL OF CANCER

The integrated landscape of driver genomic alterations in glioblastoma

(2013) Veronique Frattini et al.   NATURE GENETICS

Wnt/β-Catenin Signaling and Disease

(2012) Hans Clevers et al.   CELL

Aspirin-/TMZ-coloaded Microspheres Exert Synergistic Antiglioma Efficacy via Inhibition of β-catenin Transactivation

(2012) Zhen-Dong Shi et al.   CNS Neuroscience & Therapeutics

Drugging Wnt signalling in cancer

(2012) Paul Polakis   EMBO JOURNAL

Nuclear Translocation of β-catenin is Essential for Glioma Cell Survival

(2012) Zhendong Shi et al.   Journal of Neuroimmune Pharmacology

VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling

(2012) Lingchao Chen et al.   NEURO-ONCOLOGY

miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression

(2012) W. Zhang et al.   NEURO-ONCOLOGY

Targeting the Wnt/β-catenin signaling pathway in human cancers

(2011) Hisayuki Yao et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2

(2011) Xie-Feng Wang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Targeted Inhibition of  -Catenin/CBP Signaling Ameliorates Renal Interstitial Fibrosis

(2011) S. Hao et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

High  -catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression

(2011) J. Zhang et al.   NEURO-ONCOLOGY

Winning WNT: Race to Wnt signaling inhibitors

(2011) K. Watanabe et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells

(2010) Xiao Yue et al.   BRAIN RESEARCH

Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma

(2010) E. G. Van Meir et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Top Leads for Swine Influenza A/H1N1 Virus Revealed by Steered Molecular Dynamics Approach

(2010) Binh Khanh Mai et al.   Journal of Chemical Information and Modeling

MicroRNA roles in beta-catenin pathway

(2010) Kai Huang et al.   Molecular Cancer

Inhibition of Wnt/ -catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis

(2010) W. R. Henderson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth

(2008) P Pu et al.   CANCER GENE THERAPY